Portfolio
Corner Office
Culture
Premium
Opinion
Events
Video
Innovation
Subscribe
Sign In
Register
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Events
Video
Innovation
Subscribe
Sign In
Register
Search Query
Submit Search
Show Search
Drugs
Portfolio
Gilead Sciences’ Miracle Drug Combination
Vitaliy Katsenelson
February 23, 2016
Portfolio
Is This The Future Of Big Pharma?
Fran Hawthorne
June 3, 2011
Portfolio
ValueAct’s Rx for Drug Merger
Stephen Taub
June 22, 2010
Portfolio
Merck Offers $7.2 Billion For Millipore
March 2, 2010
Portfolio
Merck Looks To Recent Schering-Plough Merger For New Drug
Fran Hawthorne
February 10, 2010
Portfolio
Drug Royalty Bonds Attract Investors
Udayan Gupta
September 2, 2009